These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 22591803)
1. Isolation and structure characterization of related impurities in Sodium Tanshinone IIA Sulfonate by LC/ESI-MS(n) and NMR. Wang B; Wang H; Wang E; Yan W; Ye W; Li P J Pharm Biomed Anal; 2012; 67-68():36-41. PubMed ID: 22591803 [TBL] [Abstract][Full Text] [Related]
2. Determination of sodium tanshinone IIA sulfonate in plasma by liquid chromatography-electrospray ionisation-tandem mass spectrometry. Hao H; Wang G; Cui N; Li J; Ding Z Biomed Chromatogr; 2007 Nov; 21(11):1172-9. PubMed ID: 17630641 [TBL] [Abstract][Full Text] [Related]
3. Profiling the metabolic difference of seven tanshinones using high-performance liquid chromatography/multi-stage mass spectrometry with data-dependent acquisition. Sun J; Yang M; Han J; Wang B; Ma X; Xu M; Liu P; Guo D Rapid Commun Mass Spectrom; 2007; 21(14):2211-26. PubMed ID: 17569103 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study of a standardized fraction of Salvia miltiorrhiza, PF2401-SF. Park EJ; Ji HY; Kim NJ; Song WY; Kim YH; Kim YC; Sohn DH; Lee HS Biomed Chromatogr; 2008 May; 22(5):548-55. PubMed ID: 18205136 [TBL] [Abstract][Full Text] [Related]
5. Impurities preparation of sodium tanshinone IIA sulfonate by high-speed counter-current chromatography and identification by liquid chromatography/multistage tandem mass spectrometry. Chen S; Zhao X; Li Y; Yang D; Zhou T; Fan G J Chromatogr A; 2013 May; 1288():28-34. PubMed ID: 23522260 [TBL] [Abstract][Full Text] [Related]
6. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS. Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334 [TBL] [Abstract][Full Text] [Related]
7. Study of sodium tanshinone II A sulfonate tissue distribution in rat by liquid chromatography/tandem mass spectrometry. He T; Zou Q; Feng Z; Zhang Z Arzneimittelforschung; 2010; 60(11):660-6. PubMed ID: 21175038 [TBL] [Abstract][Full Text] [Related]
8. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry. Li P; Wang GJ; Li J; Hao HP; Zheng CN J Mass Spectrom; 2006 May; 41(5):670-84. PubMed ID: 16598708 [TBL] [Abstract][Full Text] [Related]
9. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry. Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378 [TBL] [Abstract][Full Text] [Related]
10. Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry. Li P; Wang GJ; Li J; Hao HP; Zheng CN J Chromatogr A; 2006 Feb; 1104(1-2):366-9. PubMed ID: 16405978 [TBL] [Abstract][Full Text] [Related]
11. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR. Raman B; Sharma BA; Mahale G; Singh D; Kumar A J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of pressurized liquid extraction and pressurized hot water extraction for tanshinone I and IIA in Salvia miltiorrhiza using LC and LC-ESI-MS. Ong ES; Len SM J Chromatogr Sci; 2004 Apr; 42(4):211-6. PubMed ID: 15154984 [TBL] [Abstract][Full Text] [Related]
13. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient. Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452 [TBL] [Abstract][Full Text] [Related]
14. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis. Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243 [TBL] [Abstract][Full Text] [Related]
15. Isolation and structure characterization of related impurities in etimicin intermediate P1 by LC/ESI-MS(n) and NMR. Wang Y; Zhang Z; Wu L; Zhang X; Wang H; Ye W; Li P J Pharm Biomed Anal; 2014 Aug; 97():97-102. PubMed ID: 24858300 [TBL] [Abstract][Full Text] [Related]
16. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride. Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955 [TBL] [Abstract][Full Text] [Related]
17. Isolation and structure characterization of related impurities in etimicin sulfate by LC/ESI-MS(n) and NMR. Wang H; Zhang Z; Xiong F; Wu L; Li P; Ye W J Pharm Biomed Anal; 2011 Jul; 55(5):902-7. PubMed ID: 21444173 [TBL] [Abstract][Full Text] [Related]
18. Study of tanshinone IIA tissue distribution in rat by liquid chromatography-tandem mass spectrometry method. Bi HC; Law FC; Zhong GP; Xu CS; Pan Y; Ding L; Chen X; Zhao LZ; Xu Q; Huang M Biomed Chromatogr; 2007 May; 21(5):473-9. PubMed ID: 17357178 [TBL] [Abstract][Full Text] [Related]
19. Characterization of tanshinones in the roots of Salvia miltiorrhiza (Dan-shen) by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Yang M; Liu A; Guan S; Sun J; Xu M; Guo D Rapid Commun Mass Spectrom; 2006; 20(8):1266-80. PubMed ID: 16548051 [TBL] [Abstract][Full Text] [Related]
20. Determination of Sodium Tanshinone IIA Sulfonate in human plasma by LC-MS/MS and its application to a clinical pharmacokinetic study. Qin W; Wang B; Lu X; Liu H; Wang L; Qi W J Pharm Biomed Anal; 2016 Mar; 121():204-208. PubMed ID: 26812478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]